Cast or Functional Ankle Orthosis After Ankle Fracture Surgery
NCT ID: NCT06559111
Last Updated: 2025-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
134 participants
INTERVENTIONAL
2005-12-01
2012-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome measures used were the functional results 3 months after surgery evaluated using two functional outcome measures (Olerud and Molander score and Kaikkonen score) and the patient return to work.
In the casting group, the traditional plaster was changed to a fiberglass one at 2 weeks and the cast treatment continued until 6 weeks. In the functional treatment group, the traditional plaster cast was changed to an reusable semi-rigid plastic orthosis (Aircast) at 2 weeks after surgery and its use was continued as an ankle support for up to 6 weeks. Follow-ups including subjective and objective evaluations were at 2, 6, 12 and 52 weeks and at 2 years postoperatively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bracing After Ankle Fracture
NCT07163091
Operative Versus Non Operative Treatment for Unstable Ankle Fractures
NCT00336752
Unimalleolar Versus Bimalleolar Fixation in Bi- or Trimalleolar Ankle Fracture
NCT01757951
Early Weightbearing Versus Non-weightbearing After Operative Treatment of an Ankle Fracture
NCT02029170
Fixation of the Posterior Malleolus in Medium-sized Trimalleolar AO Weber-B Fractures.
NCT02596529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bracing group
Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.
2-week casting followed by 4-week bracing
Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.
Casting group
Participants in the casting group had a cast for 6 weeks after the surgery.
6-week casting
Participants in the casting group had a cast for 6 weeks after the surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2-week casting followed by 4-week bracing
Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.
6-week casting
Participants in the casting group had a cast for 6 weeks after the surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* uni-, bi- or trimalleolar injury and/or fibular displacement of \>2 mm in any plane on the radiographs
Exclusion Criteria
* Pilon injury
* Inadequate co-operation
* Other severe concomitant injuries
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Töölö Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lasse Rämö
Orthopaedic Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teppo Järvinen, Prof
Role: STUDY_CHAIR
Helsinki University Central Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06121917
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.